The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richards, J. D.
Right arrow Articles by DeFranco, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richards, J. D.
Right arrow Articles by DeFranco, A. L.
The Journal of Immunology, 2001, 166: 3855-3864.
Copyright © 2001 by The American Association of Immunologists

Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen1

James D. Richards2, Shaival H. Davé3, Chih-Hao G. Chou, Alusha A. Mamchak and Anthony L. DeFranco4

Department of Microbiology and Immunology, G. W. Hooper Foundation, University of California, San Francisco, CA 94143

Signal transduction initiated by B cell Ag receptor (BCR) cross-linking plays an important role in the development and activation of B cells. Therefore, considerable effort has gone into determining the biochemical signaling events initiated by the BCR and delineating which events participate in specific biological responses to Ag. We used two inhibitors of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) 1 and MEK2, PD98059, and U0126, to assess the role the Ras-mitogen-activated protein kinase pathway plays in several BCR-induced responses. PD98059 or U0126 treatment substantially inhibited the BCR-induced activation of the extracellular signal-regulated kinase (ERK) forms of mitogen-activated protein kinase in the immature B cell line WEHI-231, in immature splenic B cells, and in mature splenic B cells. However, MEK-ERK inhibition did not block BCR-induced growth arrest or apoptosis of WEHI-231 cells or apoptosis of immature splenic B cells, indicating that the MEK-ERK pathway is not required for these events. In contrast, PD98059 and U0126 treatment did inhibit the up-regulation of specific BCR-induced proteins, including the transcription factor Egr-1 in WEHI-231 and mature splenic B cells, and the CD44 adhesion molecule and CD69 activation marker in mature splenic B cells. Moreover, both inhibitors suppressed BCR-induced proliferation of mature splenic B cells, in the absence and in the presence of IL-4. Therefore, activation of the MEK-ERK pathway is necessary for a subset of B cell responses to Ag.




This article has been cited by other articles:


Home page
Int ImmunolHome page
N. Dussault, E. Ducas, C. Racine, A. Jacques, I. Pare, S. Cote, and S. Neron
Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2
Int. Immunol., August 8, 2008; (2008) dxn090v1.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
H. MacLeod, N. Bhasin, and L. M. Wetzler
Role of Protein Tyrosine Kinase and Erk1/2 Activities in the Toll-Like Receptor 2-Induced Cellular Activation of Murine B Cells by Neisserial Porin
Clin. Vaccine Immunol., April 1, 2008; 15(4): 630 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Dye, A. Palvanov, B. Guo, and T. L. Rothstein
B Cell Receptor Cross-Talk: Exposure to Lipopolysaccharide Induces an Alternate Pathway for B Cell Receptor-Induced ERK Phosphorylation and NF-{kappa}B Activation
J. Immunol., July 1, 2007; 179(1): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Horikawa, S. W. Martin, S. L. Pogue, K. Silver, K. Peng, K. Takatsu, and C. C. Goodnow
Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors
J. Exp. Med., April 16, 2007; 204(4): 759 - 769.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Sanjo, M. Hikida, Y. Aiba, Y. Mori, N. Hatano, M. Ogata, and T. Kurosaki
Extracellular Signal-Regulated Protein Kinase 2 Is Required for Efficient Generation of B Cells Bearing Antigen-Specific Immunoglobulin G
Mol. Cell. Biol., February 15, 2007; 27(4): 1236 - 1246.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. J. J. de Gorter, J. C. M. Vos, S. T. Pals, and M. Spaargaren
The B Cell Antigen Receptor Controls AP-1 and NFAT Activity through Ras-Mediated Activation of Ral
J. Immunol., February 1, 2007; 178(3): 1405 - 1414.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ke, M. Gururajan, A. Kumar, A. Simmons, L. Turcios, R. L. Chelvarajan, D. M. Cohen, D. L. Wiest, J. G. Monroe, and S. Bondada
The Role of MAPKs in B Cell Receptor-induced Down-regulation of Egr-1 in Immature B Lymphoma Cells
J. Biol. Chem., December 29, 2006; 281(52): 39806 - 39818.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Fang, L. Xu, T. Y. Chen, J. M. Cyr, and D. M. Frucht
Anthrax Lethal Toxin Has Direct and Potent Inhibitory Effects on B Cell Proliferation and Immunoglobulin Production
J. Immunol., May 15, 2006; 176(10): 6155 - 6161.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Allsup, A. S. Kamiguti, K. Lin, P. D. Sherrington, Z. Matrai, J. R. Slupsky, J. C. Cawley, and M. Zuzel
B-Cell Receptor Translocation to Lipid Rafts and Associated Signaling Differ between Prognostically Important Subgroups of Chronic Lymphocytic Leukemia
Cancer Res., August 15, 2005; 65(16): 7328 - 7337.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Petlickovski, L. Laurenti, X. Li, S. Marietti, P. Chiusolo, S. Sica, G. Leone, and D. G. Efremov
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells
Blood, June 15, 2005; 105(12): 4820 - 4827.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Guo and T. L. Rothstein
B Cell Receptor (BCR) Cross-Talk: IL-4 Creates an Alternate Pathway for BCR-Induced ERK Activation That Is Phosphatidylinositol 3-Kinase Independent
J. Immunol., May 1, 2005; 174(9): 5375 - 5381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Hao and A. August
Actin Depolymerization Transduces the Strength of B-Cell Receptor Stimulation
Mol. Biol. Cell, May 1, 2005; 16(5): 2275 - 2284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Mizuno and T. L. Rothstein
B Cell Receptor (BCR) Cross-Talk: CD40 Engagement Enhances BCR-Induced ERK Activation
J. Immunol., March 15, 2005; 174(6): 3369 - 3376.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Y. X. Zhu, S. Benn, Z. H. Li, E. Wei, E. Masih-Khan, Y. Trieu, M. Bali, C. J. McGlade, J. O. Claudio, and A. K. Stewart
The SH3-SAM Adaptor HACS1 is Up-regulated in B Cell Activation Signaling Cascades
J. Exp. Med., September 20, 2004; 200(6): 737 - 747.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. C. Chiles
Regulation and Function of Cyclin D2 in B Lymphocyte Subsets
J. Immunol., September 1, 2004; 173(5): 2901 - 2907.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Duan, J. H. P. Chan, C. H. Wong, B. P. Leung, and W. S. F. Wong
Anti-Inflammatory Effects of Mitogen-Activated Protein Kinase Kinase Inhibitor U0126 in an Asthma Mouse Model
J. Immunol., June 1, 2004; 172(11): 7053 - 7059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Guilbault and R. J. Kay
RasGRP1 Sensitizes an Immature B Cell Line to Antigen Receptor-induced Apoptosis
J. Biol. Chem., May 7, 2004; 279(19): 19523 - 19530.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Piatelli, C. Wardle, J. Blois, C. Doughty, B. R. Schram, T. L. Rothstein, and T. C. Chiles
Phosphatidylinositol 3-Kinase-Dependent Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 and NF-{kappa}B Signaling Pathways Are Required for B Cell Antigen Receptor-Mediated Cyclin D2 Induction in Mature B Cells
J. Immunol., March 1, 2004; 172(5): 2753 - 2762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. L. Christian, R. L. Lee, S. J. McLeod, A. E. Burgess, A. H. Y. Li, M. Dang-Lawson, K. B. L. Lin, and M. R. Gold
Activation of the Rap GTPases in B Lymphocytes Modulates B Cell Antigen Receptor-induced Activation of Akt but Has No Effect on MAPK Activation
J. Biol. Chem., October 24, 2003; 278(43): 41756 - 41767.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Hokazono, T. Adachi, M. Wabl, N. Tada, T. Amagasa, and T. Tsubata
Inhibitory Coreceptors Activated by Antigens But Not by Anti-Ig Heavy Chain Antibodies Install Requirement of Costimulation Through CD40 for Survival and Proliferation of B Cells
J. Immunol., August 15, 2003; 171(4): 1835 - 1843.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. W. Sohn, H. Gu, and S. K. Pierce
Cbl-b Negatively Regulates B Cell Antigen Receptor Signaling in Mature B Cells through Ubiquitination of the Tyrosine Kinase Syk
J. Exp. Med., June 2, 2003; 197(11): 1511 - 1524.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A.-K. Yi, J.-G. Yoon, and A. M. Krieg
Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-{kappa}B activation pathways: regulation by mitogen-activated protein kinases
Int. Immunol., May 1, 2003; 15(5): 577 - 591.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Recio and G. Merlino
Hepatocyte Growth Factor/Scatter Factor Induces Feedback Up-Regulation of CD44v6 in Melanoma Cells through Egr-1
Cancer Res., April 1, 2003; 63(7): 1576 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. R. Whyburn, K. E. Halcomb, C. M. Contreras, R. Pappu, O. N. Witte, A. C. Chan, and A. B. Satterthwaite
Haploinsufficiency of B cell linker protein enhances B cell signaling defects in mice expressing a limiting dosage of Bruton's tyrosine kinase
Int. Immunol., March 1, 2003; 15(3): 383 - 392.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Jacob, D. Cooney, M. Pradhan, and K. M. Coggeshall
Convergence of Signaling Pathways on the Activation of ERK in B Cells
J. Biol. Chem., June 21, 2002; 277(26): 23420 - 23426.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Bone, S. Eckholdt, and N. A. Williams
Modulation of B lymphocyte signalling by the B subunit of Escherichia coli heat-labile enterotoxin
Int. Immunol., June 1, 2002; 14(6): 647 - 658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Piatelli, C. Doughty, and T. C. Chiles
Requirement for a hsp90 Chaperone-dependent MEK1/2-ERK Pathway for B Cell Antigen Receptor-induced Cyclin D2 Expression in Mature B Lymphocytes
J. Biol. Chem., March 29, 2002; 277(14): 12144 - 12150.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Niiro, A. Maeda, T. Kurosaki, and E. A. Clark
The B Lymphocyte Adaptor Molecule of 32 kD (Bam32) Regulates B Cell Antigen Receptor Signaling and Cell Survival
J. Exp. Med., January 7, 2002; 195(1): 143 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.